Skip to main content
Log in

Patienten mit nicht-kleinzelligem Lungenkarzinom im frühen Stadium

Resektion im Stadium IA: Wie viel reicht aus?

  • Journalclub
  • Published:
Pneumo News Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Ginsberg RJ, Rubinstein LV, Lung Cancer Study Group. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Ann Thorac Surg. 1995;60:615-23

  2. Saji H, Okada M, Tsuboi M et al. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial. Lancet. 2022;399:1607-17

  3. Altorki NK, Wang X, Wigle D et al. Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503). Lancet Respir Med. 2018;6:915-24

  4. Kohman LJ, Gu L, Altorki et al. Biopsy first: lessons learned from cancer and leukemia group B (CALGB) 140503. J Thorac Cardiovasc Surg. 2017;153:1592-7

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Adrian Gillissen.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gillissen, A. Resektion im Stadium IA: Wie viel reicht aus?. Pneumo News 15, 16–17 (2023). https://doi.org/10.1007/s15033-023-3480-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15033-023-3480-x

Navigation